Thursday , June 21 2018
Home / 2015 / September

Monthly Archives: September 2015

Is Sicker Better?

With a cure for hepatitis C finally in reach, it’s disheartening to learn that one in four hepatitis C patients hear a “no” the first time they seek treatment. According to Yale researchers, one-quarter of patients with chronic infection of the hepatitis C virus (HCV) are denied their first pre-authorization …

Read More »

Biosimilars’ Success in the US: Will Physicians Rule the Road?

By Kathleen P. Wolff, MBA Specialty Pharma Journal As the high cost of new biologic medicines sends U.S. healthcare costs soaring, payers are anxiously anticipating the introduction of biosimilar medicines – biological products, approved by FDA because they are highly similar to an already FDA-approved biological product. However, there is one …

Read More »

Timely Treatment

When one analyzes the medical records of 1.6 American adults, it turns out there’s a lot to be learned there. Researchers with the Chronic Hepatitis Cohort Study (CHeCS) did just that starting back in 2006 and tracked the ongoing health of those with hepatitis for the next numerous years. As …

Read More »